Lead Product(s) : Methylprednisolone,Inapplicable
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase II/ Phase III
Sponsor : Brielle Orthopedics | University Orthopedics Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 12, 2021
Lead Product(s) : Methylprednisolone,Inapplicable
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II/ Phase III
Sponsor : Brielle Orthopedics | University Orthopedics Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bupivacaine,Inapplicable
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase II/ Phase III
Sponsor : Pacira BioSciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Exparel for Total Shoulder Pain
Details : Undisclosed
Product Name : Exparel
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 13, 2018
Lead Product(s) : Bupivacaine,Inapplicable
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II/ Phase III
Sponsor : Pacira BioSciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cannabinol,Inapplicable
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement
Details : Undisclosed
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 18, 2018
Lead Product(s) : Cannabinol,Inapplicable
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable